The clinical course of cocaine abuse has been characterized as progressing through a number of temporal stages that advance from initial experimentation through casual use and finally to addiction. On a neurobiological level, this clinical course is paralleled by changes in the response to cocaine with repeated exposure, as well as residual changes in brain function and structure that may persist despite prolonged periods of abstinence from drug use. The studies proposed in the present application will focus on the neuroadaptations that accompany long term exposure to cocaine. We will focus on animals self-administration models, as these models provide valid predictions of human cocaine abuse. Furthermore, differences in the behavioral, pharmacological, and neurochemical responses to cocaine have been shown between self- administered cocaine and cocaine administered non-contingently. In preliminary studies we have observed progressive changes in the patterns of functional activity with continued experience with cocaine self- administration. Structure that form part of the neuroanatomical circuit mediate cocaine self-administration in its initial stages are different from those that appear to be involved later in course of experience with self-administration. Such neuroadaptations may underlie the overall progression of self-administration as it eventually leads to addiction. The overall goals of this project, then are, (1) to extend these findings to examine more closely the evolution of the functional changes associated with cocaine self-administration; (2) to determine the temporal course of adaptations in dopamine and opioid systems that may underlie these changes in functional activity as they develop over time; and (3) to examine the long term effects of novel tropane analogs synthesized in this Center that have been hypothesized as potential medications for cocaine addiction. It is hoped that this approach will provide important insights into the progressive changes that accompany cocaine abuse and provide a basis for developing pharmacological therapies treatments for addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
3P50DA006634-08S1
Application #
6104022
Study Section
Project Start
1999-02-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Siciliano, Cody A; Saha, Kaustuv; Calipari, Erin S et al. (2018) Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. J Neurosci 38:484-497
Ilyasov, Alexander A; Milligan, Carolanne E; Pharr, Emily P et al. (2018) The Endocannabinoid System and Oligodendrocytes in Health and Disease. Front Neurosci 12:733
Ding, Huiping; Kiguchi, Norikazu; Yasuda, Dennis et al. (2018) A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med 10:
Chen, R; McIntosh, S; Hemby, S E et al. (2018) High and low doses of cocaine intake are differentially regulated by dopamine D2 receptors in the ventral tegmental area and the nucleus accumbens. Neurosci Lett 671:133-139
John, William S; Martin, Thomas J; Solingapuram Sai, Kiran Kumar et al. (2018) Chronic ?9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. J Pharmacol Exp Ther 364:300-310
Siciliano, Cody A; Jones, Sara R (2017) Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration. Neuropsychopharmacology 42:1893-1904
Brodnik, Zachary D; Ferris, Mark J; Jones, Sara R et al. (2017) Reinforcing Doses of Intravenous Cocaine Produce Only Modest Dopamine Uptake Inhibition. ACS Chem Neurosci 8:281-289
Fordahl, Steve C; Jones, Sara R (2017) High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling. ACS Chem Neurosci 8:290-299
Eldeeb, Khalil; Leone-Kabler, Sandra; Howlett, Allyn C (2017) Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTP?S Binding: Total and Antibody-Targeted G? Protein-Specific Scintillation Proximity Assays. Methods Enzymol 593:1-21
Raab-Graham, Kimberly F; Niere, Farr (2017) mTOR referees memory and disease through mRNA repression and competition. FEBS Lett 591:1540-1554

Showing the most recent 10 out of 310 publications